Carlos Buesa is the founder of Oryzon Genomics. Oryzon Genomics has raised $45M in total funding. Backed by COFIDES. Based in Barcelona, Spain.
Carlos Buesa is the CEO of Oryzon Genomics, a clinical-stage biopharmaceutical company and a European leader in epigenetics. Founded in 2000, Oryzon Genomics focuses on personalized medicine for CNS disorders and has raised capital to advance its clinical development programs in oncology, hematology, and central nervous system disorders. The company's recent funding has strengthened its balance sheet to support corporate development and potential partnership discussions.
Full founder directory · Investor directory · Company funding database · Fundraising library